Synapse - Works

Results (5608)

Circulating tumor cells (CTC) in patients with metastatic castration-resistant prostate cancer (CRPC) receiving abiraterone acetate (AA) after failure of docetaxel-based chemotherapy

Meeting Abstract

Fleisher, M.; Danila, D. C.; Leversha, M.; Rathkopf, D.; Slovin, S.; Anand, A.; Koscuiszka, M.; Haqq, C.; Scher, H. I.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

A phase II study of sunitinib on a continuous dosing schedule in patients (pts) with relapsed or refractory urothelial carcinoma (UC)

Meeting Abstract

Gallagher, D. J.; Milowsky, M. I.; Gerst, S. R.; Tickoo, S.; Ishill, N.; Regazzi, A.; Trout, A.; Bajorin, D. F.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Paclitaxel (T) plus ifosfamide (I) followed by high-dose carboplatin (C) and etoposide (E) with autologous stem cell support for patients (pts) with previously treated germ cell tumors (GCT): TI-CE results and prognostic factor analysis in 107 pts

Meeting Abstract

Feldman, D. R.; Sheinfeld, J.; Bajorin, D. F.; Fischer, P.; Turkula, S.; Ishill, N.; Patil, S.; Bains, M.; Bosl, G. J.; Motzer, R. J.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Quality of life (QOL) with sunitinib versus interferon-alfa (IFN-α) as first-line therapy in patients with metastatic renal cell carcinoma (mRCC): Final results

Meeting Abstract

Cella, D.; Michaelson, M. D.; Cappelleri, J. C.; Bushmakin, A. G.; Charbonneau, C.; Kim, S. T.; Li, J. Z.; Motzer, R. J.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Phase II multicenter study of abiraterone acetate (AA) plus prednisone therapy in docetaxel-treated castration-resistant prostate cancer (CRPC) patients (pts): Impact of prior ketoconazole (keto)

Meeting Abstract

Danila, D. C.; de Bono, J.; Ryan, C. J.; Denmeade, S.; Smith, M.; Taplin, M.; Bubley, G.; Molina, A.; Haqq, C.; Scher, H. I.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Pain and analgesic use in men with metastatic prostate cancer

Meeting Abstract

Basch, E. M.; Sit, L.; Fruscione, M.; Burke, L.; Kane, R.; George, D.; Carducci, M. A.; Matthew, P.; Beer, T. M.; Scher, H. I.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Patient-reported outcomes in a randomized trial of everolimus with metastatic renal cell carcinoma patients

Meeting Abstract

Beaumont, J.; Cella, D.; Hutson, T.; Bracarda, S.; Grunwald, V.; Thompson, J.; Ravaud, A.; Urbanowitz, G.; Hollaender, N.; Motzer, R.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Prediction of treatment response in subtypes of non-Hodgkin's lymphoma by in vivo (31)P MR spectroscopy before treatment

Meeting Abstract

Arias-Mendoza, F.; Leach, M. O.; Koutcher, J. A.; Griffiths, J. R.; Heerschap, A.; Glickson, J. D.; O'Connor, O. A.; Brown, T. R.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Vascular thromboembolic events in patients (pts) with advanced urothelial cancer (UC) treated with carboplatin/gemcitabine alone or in combination with bevacizumab

Meeting Abstract

Apolo, A. B.; Regazzi, A. M.; Milowsky, M. I.; Bajorin, D. F.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Cisplatin-based chemotherapy is associated with an unacceptably high incidence of thromboembolic events: A large retrospective analysis

Meeting Abstract

Moore, R. A.; Adel, N. G.; Bhutani, M.; Tabbara, N. E.; Landau, H.; Nimer, S. D.; Feldman, D. R.; Hassoun, H.
Blood (2009)

Fulltext@MSK | Save